Long

Shock and Awe for undervalued Tetra Bio Pharma

More gains ahead. Likely to see new 52 week highs on legalization (Oct/18) ending on announcement of stage 3 trials.
Beyond Technical AnalysisTechnical IndicatorsTrend Analysis

Disclaimer